Low frequency of MECP2 mutations in mentally retarded males. (scientific article)

Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group

Q35249493

MECP2 mutation in non-fatal, non-progressive encephalopathy in a male

Q35436994

Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein

Q35437213

Rett syndrome: Criteria for inclusion and exclusion

Q40562627

Screening a large reference sample to identify very low frequency sequence variants: comparisons between two genes

Q43560550

MECP2 is highly mutated in X-linked mental retardation

Q48369835

MECP2 mutation in male patients with non-specific X-linked mental retardation.

Q50312539

De novo MECP2 frameshift mutation in a boy with moderate mental retardation, obesity and gynaecomastia.

Q51955909

Polymorphisms in the C-terminal domain of MECP2 in mentally handicapped boys: implications for genetic counselling.

Q51958928

Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location.

Q54493491

Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males

Q57206738

In-frame deletion inMECP2 causes mild nonspecific mental retardation

Q58061411

Two affected boys in a Rett syndrome family: clinical and molecular findings

Q73172439

MeCP2 mutations in children with and without the phenotype of Rett syndrome

Q74009717

Somatic mosaicism for a MECP2 mutation associated with classic Rett syndrome in a boy

Q77769287

P433

issue

P304

page(s)

487-490

P577

publication date

2002-08-01

P1433

published in

European Journal of Human Genetics

Q2155433

P1476

title

Low frequency of MECP2 mutations in mentally retarded males.

P478

volume

Reverse relations

cites work (P2860)

Q34699414	Advances in understanding of fragile X pathogenesis and FMRP function, and in identification of X linked mental retardation genes.
Q37962183	Algorithmic approach for methyl-CpG binding protein 2 (MECP2) gene testing in patients with neurodevelopmental disabilities
Q36286566	Does genotype predict phenotype in Rett syndrome?
Q50687234	Functional characterization of missense variants in the creatine transporter gene (SLC6A8): improved diagnostic application.
Q44153653	Identification of a family with nonspecific mental retardation (MRX79) with the A140V mutation in the MECP2 gene: is there a need for routine screening?
Q51946326	MECP2 analysis in mentally retarded patients: implications for routine DNA diagnostics.
Q35597795	MECP2 and beyond: phenotype-genotype correlations in Rett syndrome
Q51935037	MECP2 mutation analysis in patients with mental retardation.
Q50225101	MECP2 mutations in Czech patients with Rett syndrome and Rett-like phenotypes: novel mutations, genotype-phenotype correlations and validation of high-resolution melting analysis for mutation scanning
Q36757032	MECP2 mutations in males.
Q51946429	MECP2 mutations or polymorphisms in mentally retarded boys: diagnostic implications.
Q47626064	Macrocephalic mental retardation associated with a novel C-terminal MECP2 frameshift deletion
Q28260093	Mechanisms of disease: neurogenetics of MeCP2 deficiency
Q28240924	Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized
Q43804873	Monogenic X-linked mental retardation: is it as frequent as currently estimated? The paradox of the ARX (Aristaless X) mutations.
Q28188406	Mutations and polymorphisms in the human methyl CpG-binding protein MECP2
Q41938321	Mutations in the MECP2 gene are not a major cause of Rett syndrome-like or related neurodevelopmental phenotype in male patients
Q34205119	Nonsyndromic X-linked mental retardation: where are the missing mutations?
Q28255289	Rett syndrome: a prototypical neurodevelopmental disorder
Q24674633	Rett syndrome: clinical review and genetic update
Q36545755	Rett syndrome: new clinical and molecular insights.
Q90401570	The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2
Q44830611	Update on the genetics of X-linked mental retardation
Q33911020	X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of rett syndrome
Q35026980	X-linked mental retardation: vanishing boundaries between non-specific (MRX) and syndromic (MRXS) forms